Abstract
Aim The overarching aim of this research was to 1) Understand the mobility experiences, supported mobility device (SMD) use, and desired participation outcomes of people with cerebral palsy (CP) across the lifespan; and 2) Describe how perspectives of rehabilitation care and professional resources may influence mobility decision-making processes and outcomes. The aim of this study was to understand the lived experience of SMD provision and use with a focus group guide co-developed by stakeholders.
Methods Focus groups were conducted with 164 participants (people with CP, caregivers, and healthcare providers) across four US cities. Sessions were audio-recorded, transcribed, and analyzed using constant comparison.
Results Six themes emerged. Five presented across all stakeholder groups: 1) The System is Broken; 2) Equipment is Simultaneously Liberating and Restricting; 3) Adaptation Across the Lifespan; 4) Designed for Transport, not for Living; and 5) Sharing Our Stories and Sharing Resources. One theme was specific to healthcare provider groups: Caught in the Middle.
Interpretation This qualitative study underscores the simultaneous value and frustration associated with SMD, and the need to improve connections and resource networks within the CP community to improve SMD design and provision processes across device types and across the lifespan for people with CP.
What this paper adds
One of the largest qualitative data sets specific to supportive mobility devices across ages and functional levels.
Results indicate SMD is most often equated with freedom, participation, and independence.
Frustrations with SMD across the lifespan persist related to design, function, cost, and maintenance.
Stakeholders in the CP community are seeking greater networking and resource-sharing to enhance SMD provision processes.
Access to appropriate SMD across the lifespan and the need for systems improvement is critical.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the American Academy for Cerebral Palsy and Developmental Medicine and the Pedal with Pete Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All study procedures were reviewed and received ethical approval from the Seattle Children's Research Institute IRB.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
List of Abbreviations
- SMD
- Supportive Mobility Device
- CP
- Cerebral Palsy
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.